SUI
Carl Rudolf Blankart
Health systems
Antimicrobial Market
Health Technology Assessment
Health Care Regulation
Market Access
Professor of Regulatory Affairs, University of Bern, Switzerland
University of Bern

leadership vision

I want to address complex regulatory challenges to drive change in the healthcare system for the benefit of the society. In my role as a supervisor and leader, I seek to open doors so that individuals can find their own path and develop their own skills. The better trained and prepared the future experts are, the more we can achieve together.

my story

As a member of the fifth cohort of the Sciana Network, we are working on the One Health challenge.

On a micro level, I find it exciting to work with inspiring, motivated individuals from Germany, the United Kingdom and Switzerland. On a macro level, the Sciana network opens many doors for me to achieve my leadership goals.

about me

Carl Rudolf Blankart is a researcher at the KPM Center for Public Management at the University of Bern and the Swiss Institute for Translational and Entrepreneurial Medicine (sitem-insel). He chairs the Economics Cluster at the University of Bern's Multidisciplinary Center for Infectious Diseases (MCID). He holds a master's degree in Industrial Engineering from the Technische Universität Berlin (Dipl.-Ing.) and a doctorate from the Universität Hamburg (Dr. rer. pol.). Prior to his appointment at the University of Bern, he held positions at the Universität Hamburg and was a visiting researcher at the Centre for Health Policy at Imperial College London and the Brown University School of Public Health in the US. Dr. Blankart's research is situated at the intersection of medicine, management, and law, and aims to improve the pathway from idea to patient. He focuses on regulatory and reimbursement frameworks for medicinal products and medical devices, exploring how these frameworks can improve health provision. Dr. Blankart is particularly passionate about translating research results into practice. To this end, he is involved with the Swiss Round Table on Antibiotics (president) and the Swiss Association for the Promotion of Self-Management (president). Dr. Blankart is also a member of the board of directors of Decomplix AG. In addition, he provides advisory services to private and public organizations on health policy and regulatory issues.

more fellows

GBR
Adam Doyle
Sussex Clinical Commissioning Groups
Adam Doyle
Chief Executive Officer/National Director - System Development, NHS Sussex/NHS England, United Kingdom
GER
Michael Moran
AbbVie GmbH & Co. KG
Michael Moran
Medical Director and Therapeutic Area Lead, Global Medical Affairs, AbbVie GmbH & Co. KG, Germany
SUI
Carl Rudolf Blankart
University of Bern
Carl Rudolf Blankart
Professor of Regulatory Affairs, University of Bern, Switzerland
GER
Wiebke Loebker
Federal Institute of Drugs and Medical Product
Wiebke Loebker
Personal Assistant of the President; Federal Institute of Drugs and Medical Products; Head of Innovation Office, Change Management Staff Unit, Germany
SUI
Oliver Reich
SWICA Health Organisation
Oliver Reich
Director, santé24, Switzerland
GBR
Rachel Carey
Zinc
Rachel Carey
Chief Missions and Science Officer, Zinc, United Kingdom
GBR
Rishi Das Gupta
Health Innovation Network (HIN)
Rishi Das Gupta
Chief Executive, Health Innovation Network (HIN), United Kingdom
GBR
Judith Proctor
Edinburgh Integration Joint Board
Judith Proctor
Chief Officer, Edinburgh Integration Joint Board, Scotland, United Kingdom
SUI
Claudia Witt
University of Zurich
Claudia Witt
Professor of Medicine, University of Zurich; Director, Institute for Complementary and Integrative Medicine; University Hospital Zurich, Switzerland
SUI
Nicola von Lutterotti
Self-employed
Nicola von Lutterotti
President of the Board of Trustees, the Max-Planck Institute for Immunobiology and Epigenetics, Freiburg; Science Writer; Author, Germany
GBR
Adrian Jonas
NHS England
Adrian Jonas
Chief Analyst for the North West Region, NHS England, United Kingdom
GBR
Lawrence Tallon
Guy's and St Thomas' NHS Foundation Trust
Lawrence Tallon
Chief Executive Officer, Medicines and Healthcare products Regulatory Agency, United Kingdom
GBR
Timothy Taylor
NHSEI Midlands
Timothy Taylor
Associate Medical Director, NHSEI Midlands; Consultant Neuroradiologist, Nottingham University Hospitals NHS Trust, United Kingdom
GER
Ulrike Streit
University Hospital Frankfurt
Ulrike Streit
Managing senior physician in radiology, The Klinikum rechts der Isar, The University Hospital of the Technical University of Munich, Germany
GER
Lorena Dini
Charité Universitätsmedizin Berlin
Lorena Dini
Senior Researcher, Charité Universitätsmedizin Berlin, Germany
GER
Thorsten Langer
University of Freiburg, Medical Center
Thorsten Langer
Professor, Director Social Pediatric Center, Children's Hospital Freiburg, Germany

Meet the Partners

Sciana: The Health Leaders Network is a programme supported jointly by the Health Foundation (UK), Careum (CH) and the Bosch Health Campus (DE) in collaboration with Salzburg Global.